标普生物科技LOF(161127)

动态评分: 5.92分

投资组合

报告日期 名称 比例
2017-12-31 Vanda Pharmaceuticals Inc 0.43%
2017-12-31 克律克斯生物制药 0.42%
2017-12-31 REGENXBIO Inc 0.42%
2017-12-31 Intellia Therapeutics Inc 0.41%
2017-12-31 Cara Therapeutics Inc 0.39%
2017-12-31 Enanta Pharmaceuticals Inc 0.38%
2017-12-31 La Jolla Pharmaceutical Co 0.38%
2017-12-31 Epizyme Inc 0.32%
2017-12-31 莱斯康制药 0.32%
2017-12-31 Alaunos Therapeutics Inc 0.31%
2017-12-31 Mirati Therapeutics Inc 0.29%
2017-12-31 CytomX Therapeutics Inc 0.27%
2017-12-31 Cytokinetics Inc 0.27%
2017-12-31 Coherus BioSciences Inc 0.26%
2017-12-31 Foundation Medicine Inc 0.26%
2017-12-31 BioCryst Pharmaceuticals Inc 0.25%
2017-12-31 Akebia Therapeutics Inc 0.24%
2017-12-31 Inovio制药 0.24%
2017-12-31 Travere Therapeutics Inc 0.24%
2017-12-31 普罗基尼克斯制药 0.23%

投资模拟

公告&资料